Halozyme Therapeutics, Inc. (HALO)
67.54
-0.16
(-0.24%)
USD |
NASDAQ |
Dec 31, 14:53
Halozyme Therapeutics Price: 67.54 for Dec. 31, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 207.18 |
| Merck & Co., Inc. | 105.26 |
| AIM ImmunoTech, Inc. | 1.08 |
| Bristol Myers Squibb Co. | 54.09 |
| Protalix Biotherapeutics, Inc. | 1.80 |
Price Related Metrics
| PE Ratio | 14.20 |
| PS Ratio | 6.822 |
| PEG Ratio | 0.2472 |
| Price to Book Value | 15.76 |
| Price to Free Cash Flow | 14.07 |
| Earnings Yield | 7.04% |
| Market Cap | 7.943B |
| PEGY Ratio | 0.2472 |
| Operating PE Ratio | 11.50 |
| Normalized PE Ratio | 14.20 |